We have in vitro tested the ability of common, commercially available, cholinesterase reactivators (pralidoxime, obidoxime, methoxime, trimedoxime and HI-6) to reactivate human acetylcholinesterase (AChE), inhibited by five structurally different organophosphate pesticides and inhibitors (paraoxon, dichlorvos, DFP, leptophos-oxon and methamidophos). We also tested reactivation of human butyrylcholinesterase (BChE) with the aim of finding a potent oxime, suitable to serve as a “pseudocatalytic” bioscavenger in combination with this enzyme. Such a combination could allow an increase of prophylactic and therapeutic efficacy of the administered enzyme. According to our results, the best broad-spectrum AChE reactivators were trimedoxime and obid...
1. SUMMARY Originally organophosphorus compounds were used as pesticides. Unfortunately, their irrev...
Stanislav Sopr: PREPARATION OF BISQUARTERNARY NON-SYMETRIC ACETYLCHOLINESTERASE REACTIVATORS Abstrac...
Background: Oxime K033 was considered a promising drug candidate originally developed for the treatm...
AbstractOrganophosphate (OP) compounds exert inhibition on cholinesterase (ChE) activity by irrevers...
Nerve agents and oxon forms of organophosphorus pesticides act as strong irreversible inhibitors of ...
Nerve agents and pesticides belong to the group of organophosphates. They are able to inhibit irreve...
In vitro reactivation of choliesterases after pesticides inhibition Organophosphate pesticides are t...
Organophosphates (OPs) irreversibly inhibit acetylcholinesterase (AChE) and butyrylcholinesterase (B...
QUESTIONS OF THE IN VITRO INHIBITION OF CHOLINESTERASES BY SELECTED ORGANOPHOSPHORUS PESTICIDES Hele...
International audienceOrganophosphorus nerve agents (OPNAs) are highly toxic compounds that represen...
Abstract Toxicity of organophosphorus compounds (OPs) remains a major public health concern due to t...
Four novel bisquaternary aldoxime cholinesterase reactivators differing in their chemical structure ...
Four novel bisquaternary aldoxime cholinesterase reactivators differing in their chemical structure ...
Background: Obidoxime is the only one reactivator of acetylcholinesterase (AChE) approved in Czech R...
Organophosphate compounds (OPCs) are commonly used as pesticides and were developed as nerve agents ...
1. SUMMARY Originally organophosphorus compounds were used as pesticides. Unfortunately, their irrev...
Stanislav Sopr: PREPARATION OF BISQUARTERNARY NON-SYMETRIC ACETYLCHOLINESTERASE REACTIVATORS Abstrac...
Background: Oxime K033 was considered a promising drug candidate originally developed for the treatm...
AbstractOrganophosphate (OP) compounds exert inhibition on cholinesterase (ChE) activity by irrevers...
Nerve agents and oxon forms of organophosphorus pesticides act as strong irreversible inhibitors of ...
Nerve agents and pesticides belong to the group of organophosphates. They are able to inhibit irreve...
In vitro reactivation of choliesterases after pesticides inhibition Organophosphate pesticides are t...
Organophosphates (OPs) irreversibly inhibit acetylcholinesterase (AChE) and butyrylcholinesterase (B...
QUESTIONS OF THE IN VITRO INHIBITION OF CHOLINESTERASES BY SELECTED ORGANOPHOSPHORUS PESTICIDES Hele...
International audienceOrganophosphorus nerve agents (OPNAs) are highly toxic compounds that represen...
Abstract Toxicity of organophosphorus compounds (OPs) remains a major public health concern due to t...
Four novel bisquaternary aldoxime cholinesterase reactivators differing in their chemical structure ...
Four novel bisquaternary aldoxime cholinesterase reactivators differing in their chemical structure ...
Background: Obidoxime is the only one reactivator of acetylcholinesterase (AChE) approved in Czech R...
Organophosphate compounds (OPCs) are commonly used as pesticides and were developed as nerve agents ...
1. SUMMARY Originally organophosphorus compounds were used as pesticides. Unfortunately, their irrev...
Stanislav Sopr: PREPARATION OF BISQUARTERNARY NON-SYMETRIC ACETYLCHOLINESTERASE REACTIVATORS Abstrac...
Background: Oxime K033 was considered a promising drug candidate originally developed for the treatm...